IP Library Granted Patent US 12,728,192
Granted Patent B2
US 12,728,192 · App. 18/038,360 · Granted Sep 8, 2026

Fluid drainage or delivery device for treatment site

Inventors: Brian Roderick Ward (Pukekohe, NZ); Isaac Tristram Tane Mason (Auckland, NZ); Hamish Joshua Rose (Auckland, NZ); Alister Todd Jowsey (Auckland, NZ); Michael Andrew Loveland (Auckland, NZ); Liam Joseph Douglas (Auckland, NZ); Samuel Barry Turner (Auckland, NZ); Dorrin Asefi (Auckland, NZ); Sean James Gorman (Auckland, NZ); Henry David Chittock (Auckland, NZ)
Assignee: AROA BIOSURGERY LIMITED
A61M1/90A61M1/915A61M1/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,728,192
App. No.
18/038,360
Granted
Sep 8, 2026
Kind
B2
Abstract

A bioresorbable device for implantation in the body of a patient for administering fluid and/or negative pressure to a treatment site. The device includes a bioresorbable resilient truss for holding two tissue surfaces spaced apart. The truss has two flexible elongate wall members wound in a manner to define a channel, the two elongate wall members intersecting each other periodically at a plurality of cross-over nodes. The truss also includes at least two flexible elongate bracing members, each bracing member being mechanically linked to the two elongate wall members at a plurality of the cross-over nodes.

Claims (45)

1 . A bioresorbable device for implantation in the body of a patient for administering fluid and/or negative pressure to a treatment site, the device comprising a bioresorbable resilient truss for holding two tissue surfaces spaced apart, the truss comprising:

two flexible elongate wall members wound in a manner to define a channel, the two elongate wall members intersecting each other periodically at a plurality of cross-over nodes; and

at least two flexible elongate bracing members, wherein each bracing member loops around the wall members or the wall members loop around the respective bracing member to mechanically link and fixably interlock each bracing member to each of the two elongate wall members at a plurality of the cross-over nodes.

2 . A device as claimed in claim 1 , wherein the bracing members extend generally longitudinally along a side of the channel.

3 . A device as claimed in claim 2 , wherein the bracing members are provided on opposite sides of the channel.

4 . A device as claimed in claim 1 , wherein the wall members are wound to form a porous wall such that fluid from the treatment site can drain from the channel and/or fluid can be delivered to the treatment site from the channel.

5 . A device as claimed in claim 1 , wherein the device is generally tubular.

6 . A device as claimed in claim 1 , wherein each bracing member comprises a main filament that forms a full 360 degree loop around the wall members at the respective cross-over nodes.

7 . A device as claimed in claim 6 , wherein each bracing member main filament loops 720 degrees around the wall members at the respective cross-over nodes.

8 . A device as claimed in claim 6 , wherein each bracing member further comprises a secondary filament that twists around the main filament.

9 . A device as claimed in claim 1 , wherein each bracing member comprises two filaments twisted together, with the wall members held between the two filaments at the respective cross-over nodes.

10 . A device as claimed in claim 9 , wherein there is at least one full twist of the filaments between adjacent interlinked cross-over nodes.

11 . A device as claimed in claim 1 , wherein each bracing member is mechanically linked and fixably interlocked to the two elongate wall members at the respective cross-over nodes by way of the wall members looping around the respective bracing member.

12 . A device as claimed in claim 1 , wherein each elongate wall member is generally helical.

13 . A device as claimed in claim 12 , wherein a first one of the wall members is generally helical with a first pitch length, and a second one of the wall members is generally helical with a second pitch length that is the same as the first pitch length.

14 . A device as claimed in claim 12 , wherein the two wall members are oppositely wound.

15 . A device as claimed in claim 12 , wherein each wall member has a pitch length that is between about 2 mm and about 10 mm.

16 . A device as claimed in claim 15 , wherein each wall member has a pitch length of about 4 mm.

17 . A device as claimed in claim 1 , wherein a first one of the wall members is a left-side wall member, and a second one of the wall members is a right-side wall member.

18 . A device as claimed in claim 1 , wherein the wall members and bracing members comprise suture.

19 . A device as claimed in claim 1 , wherein the truss forms a flexible tube having a round or oval cross-section.

20 . A device as claimed in claim 19 , wherein the channel has a cross-sectional area of at least 16 mm 2 .

21 . A device as claimed in claim 1 , further comprising a flexible bioresorbable sheet, the sheet forming at least a portion of a wall of the channel.

22 . A device as claimed in claim 21 , wherein the flexible bioresorbable sheet is wrapped around the truss.

23 . A device as claimed in claim 22 , comprising a plurality of apertures in the flexible bioresorbable sheet to permit fluid flow into the channel.

24 . A device as claimed in claim 21 , comprising two flexible bioresorbable sheets, wherein the channel is formed between facing surfaces of the two flexible sheets.

25 . A device as claimed in claim 24 , comprising a plurality of apertures in one or both flexible sheets along a wall of the channel to permit fluid flow into the channel.

26 . A device as claimed in claim 21 , wherein the flexible sheet comprises one or more layers of extracellular matrix (ECM) or polymeric material.

27 . A device as claimed in claim 26 , wherein the ECM is formed from decellularised propria-submucosa of a ruminant forestomach.

28 . A device as claimed in claim 1 , comprising a port in fluid communication with the one or more channels and being connectable to a source of negative pressure or positive pressure.

29 . A device as claimed in claim 1 , wherein the treatment site is a space between surfaces of muscle tissue, connective tissue or skin tissue that have been separated during surgery or as a result of trauma.

30 . A device as claimed in claim 1 , wherein each bracing member loops around the wall members or the wall members loop around each bracing member to mechanically link and fixably interlock both bracing members to both of the two elongate wall members at a plurality of the cross-over nodes.

31 . A device as claimed in claim 30 , wherein each bracing member loops around the wall members or the wall members loop around each bracing member to mechanically link and fixably interlock both bracing members to both of the two elongate wall members at each of the plurality of cross-over nodes.

32 . A device as claimed in claim 30 , wherein each bracing member loops around the wall members or the wall members loop around each bracing member to mechanically link and fixably interlock both bracing members to both of the two elongate wall members at a plurality of the cross-over nodes to prevent or minimize relative movement between said elongate wall members and to prevent or minimize movement of each bracing member relative to the cross-over node.

33 . A system for draining fluid from a treatment site or delivering fluid to a treatment site in the body of a patient comprising:

(i) a device as claimed in claim 1 ;

(ii) a conduit releasably coupled to either the port of the device or to a fluid impermeable dressing;

(iii) a reservoir located external to the body of the patient, the reservoir in fluid communication with the conduit for receiving fluid from the conduit or delivering fluid to the conduit; and

(iv) a source of pressure coupled to the conduit for delivering positive pressure or negative pressure to the device.

34 . A system as claimed in claim 33 , wherein the source of pressure is capable of delivering negative pressure to the device so that fluid is drained from the treatment site into the device and transferred through the conduit to the reservoir.

35 . A system as claimed in claim 34 , wherein the negative pressure source is arranged to draw a treatment fluid through the device.

36 . A method of draining fluid from a treatment site or delivering fluid to a treatment site in the body of a patient comprising:

(i) implanting a device of claim 1 at the treatment site;

(ii) coupling a conduit to the device, the conduit being connected to at least one reservoir located external to the body of the patient for receiving fluid from the conduit or delivering fluid to the conduit; and

(iii) delivering negative pressure to the device so that fluid from the treatment site is drawn into the device for removal and/or so that treatment fluid is drawn into the device and delivered to the treatment site.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: ASEFI, DORRIN; CHITTOCK, HENRY DAVID; DOUGLAS, LIAM JOSEPH; GORMAN, SEAN JAMES; JOWSEY, ALISTER TODD; LOVELAND, MICHAEL ANDREW; MASON, ISAAC TRISTRAM TANE; O'NEILL, BRENDAN ANDREW; ROSE, HAMISH JOSHUA; TRINIDADE, NIGEL; TURNER, SAMUEL BARRY; WARD, BRIAN RODERICK; WILLIAMSON, SARAH FRANCES
To: AROA BIOSURGERY LIMITED
Reel/Frame 065609/0785 →
Continuity (4)
Provisional Application 63279915 · Nov 16, 2021
Provisional Application 63217889 · Jul 2, 2021
Provisional Application 63117995 · Nov 24, 2020
Related Publication 20240001022A1 · Jan 4, 2024
References Cited (111)
US 5088483A · Heinecke · 1992 [cited by applicant]
US 5180375A · Feibus · 1993 [cited by applicant]
US 5843168A · Dang · 1998 [cited by examiner]
US 6159187A · Park et al. · 2000 [cited by applicant]
US 7883494B2 · Martin · 2011 [cited by applicant]
US 8403913B2 · Dein · 2013 [cited by applicant]
US 8604124B2 · Yamaguchi et al. · 2013 [cited by applicant]
US 8623047B2 · Cornet et al. · 2014 [cited by applicant]
US 8777911B2 · Heagle et al. · 2014 [cited by applicant]
US 8939933B2 · Santora et al. · 2015 [cited by applicant]
US 10155071B2 · Locke et al. · 2018 [cited by applicant]
US 10682446B2 · Askem et al. · 2020 [cited by applicant]
US 20020161346A1 · Lockwood et al. · 2002 [cited by applicant]
US 20030199817A1 · Thompson et al. · 2003 [cited by applicant]
US 20070185426A1 · Ambrosio et al. · 2007 [cited by applicant]
US 20090005746A1 · Nielsen et al. · 2009 [cited by applicant]
US 20090198167A1 · Ambrosio · 2009 [cited by applicant]
US 20090275922A1 · Coulthard et al. · 2009 [cited by applicant]
US 20090281526A1 · Kenny et al. · 2009 [cited by applicant]
US 20100160877A1 · Kagan et al. · 2010 [cited by applicant]
US 20100249688A1 · Ambrosio et al. · 2010 [cited by applicant]
US 20100298792A1 · Weston et al. · 2010 [cited by applicant]
US 20100305490A1 · Coulthard et al. · 2010 [cited by applicant]
US 20110028917A1 · Hall et al. · 2011 [cited by applicant]
US 20110213319A1 · Blott et al. · 2011 [cited by applicant]
US 20120022436A1 · Bradley et al. · 2012 [cited by applicant]
US 20120071814A1 · Fallin et al. · 2012 [cited by applicant]
US 20120135225A1 · Colas et al. · 2012 [cited by applicant]
US 20120330253A1 · Robinson et al. · 2012 [cited by applicant]
US 20130090588A1 · Buus et al. · 2013 [cited by applicant]
US 20130110058A1 · Adie et al. · 2013 [cited by applicant]
US 20130296815A1 · Boehringer et al. · 2013 [cited by applicant]
US 20140276288A1 · Randolph et al. · 2014 [cited by applicant]
US 20140303261A1 · Ramjit et al. · 2014 [cited by applicant]
US 20140316328A1 · Rajendran et al. · 2014 [cited by applicant]
US 20150018785A1 · Vess et al. · 2015 [cited by applicant]
US 20150273181A1 · Leeflang et al. · 2015 [cited by applicant]
US 20150320911A1 · Sun et al. · 2015 [cited by applicant]
US 20160022500A1 · Tumey · 2016 [cited by applicant]
US 20160106892A1 · Hartwell · 2016 [cited by applicant]
US 20160325028A1 · Locke et al. · 2016 [cited by applicant]
US 20160346444A1 · Zamierowski · 2016 [cited by applicant]
US 20170065458A1 · Mumby et al. · 2017 [cited by applicant]
US 20170189239A1 · Dunn · 2017 [cited by applicant]
US 20170360544A1 · Ward et al. · 2017 [cited by applicant]
US 20180104391A1 · Luxon et al. · 2018 [cited by applicant]
US 20180214313A1 · Pratt et al. · 2018 [cited by applicant]
US 20180214315A1 · Mercer et al. · 2018 [cited by applicant]
US 20180353336A1 · Locke et al. · 2018 [cited by applicant]
US 20180353339A1 · Locke et al. · 2018 [cited by applicant]
US 20190008694A1 · Piotrowski et al. · 2019 [cited by applicant]
US 20190117466A1 · Kazala et al. · 2019 [cited by applicant]
US 20190117861A1 · Locke et al. · 2019 [cited by applicant]
US 20190201595A1 · Jardret et al. · 2019 [cited by applicant]
US 20190321232A1 · Jardret et al. · 2019 [cited by applicant]
US 20200060879A1 · Edwards et al. · 2020 [cited by applicant]
US 20200129338A1 · Gardiner et al. · 2020 [cited by applicant]
US 20200246604A1 · Asefi et al. · 2020 [cited by applicant]
US 20200253788A1 · Rehbein et al. · 2020 [cited by applicant]
US 20200337906A1 · Long et al. · 2020 [cited by applicant]
US 20200368072A1 · McNulty et al. · 2020 [cited by applicant]
US 20210077302A1 · Carroll et al. · 2021 [cited by applicant]
US 20210187171A1 · Collinson et al. · 2021 [cited by applicant]
US 20220249763A1 · Asefi et al. · 2022 [cited by applicant]
US 20240000616A1 · Ward et al. · 2024 [cited by applicant]
US 20240293264A1 · Ward et al. · 2024 [cited by applicant]
US 20240358910A1 · Ward et al. · 2024 [cited by applicant]
US 20240390190A1 · Ward et al. · 2024 [cited by applicant]
AU 2015210406A1 · 2015 [cited by applicant]
DE 202019102362U1 · 2020 [cited by applicant]
JP 2013517839A · 2013 [cited by applicant]
JP 2014511222A · 2014 [cited by applicant]
JP 2015198975A · 2015 [cited by applicant]
JP 2015532147A · 2015 [cited by applicant]
JP 2017517312A · 2017 [cited by applicant]
JP 2017518793A · 2017 [cited by applicant]
JP 2017527336A · 2017 [cited by applicant]
JP 2019500964A · 2019 [cited by applicant]
WO 1994027697A1 · 1994 [cited by applicant]
WO 2007106589A2 · 2007 [cited by applicant]
WO 2009003886A1 · 2009 [cited by applicant]
WO 2011091045A2 · 2011 [cited by applicant]
WO 2012106590A2 · 2012 [cited by applicant]
WO 2019070133A1 · 2019 [cited by applicant]
WO WO2019070133 · 2019 [cited by examiner]
WO 2019113275A1 · 2019 [cited by applicant]
WO 2019140444A1 · 2019 [cited by applicant]
WO 2019226454A1 · 2019 [cited by applicant]
WO 2020226511A1 · 2020 [cited by applicant]
WO 2021070051A2 · 2021 [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2021/050205, dated May 30, 2023, 11 pages. [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2018/050134, dated Apr. 8, 2020, 6 pages. [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2021/050206, dated May 30, 2023, 6 pages. [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2021/050207, dated May 30, 2023, 9 pages. [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2021/050208, dated May 30, 2023, 10 pages. [cited by applicant]
International Preliminary Report on Patentability, PCT/NZ2022/050090, dated Dec. 14. 2023, 8 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2018/050134, dated Jan. 10, 2019, 11 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2020/050044, dated Aug. 3, 2020, 20 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2021/050205, dated Mar. 25, 2022, 24 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2021/050206, dated Feb. 22, 2022, 14 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2021/050207, dated Feb. 22, 2022, 25 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2021/050208, dated Mar. 1, 2022, 15 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/NZ2022/050090, dated Oct. 12, 2022, 11 pages. [cited by applicant]
Extended European Search Report, European Application No. 21898777.4, dated Oct. 24, 2024, 7 pages. [cited by applicant]
U.S. Appl. No. 16/753,725, filed Apr. 3, 2020, Dorrin Asefi. [cited by applicant]
U.S. Appl. No. 18/038,356, filed May 23, 2023, Brian Roderick Ward. [cited by applicant]
U.S. Appl. No. 18/038,365, filed May 23, 2023, Brian Roderick Ward, US 20250000616. [cited by applicant]
U.S. Appl. No. 17/608,305, filed Nov. 2, 2021, Dorrin Asefi, US20220249763. [cited by applicant]
U.S. Appl. No. 18/038,353, filed May 23, 2023, Brian Roderick Ward. [cited by applicant]
U.S. Appl. No. 18/575,184, filed Dec. 28, 2023, Brian Roderick Ward. [cited by applicant]
Extended European Search Report, European Application No. 21898775.8, dated Sep. 17, 2024, 8 pages. [cited by applicant]